ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,693, issued on Oct. 14, was assigned to The George Washington University (Washington) and University of Utah Research Foundation (Salt Lake City).

"Targeting STAT sumoylation to enhance immune responses" was invented by Alberto Bosque-Pardos (Washington), Amanda Beatriz Rodrigues Barreto De Macedo (Washington), Eric S. Sorensen (Washington) and Vicente Planelles (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure generally relates to compositions and methods for ex vivo expansion of immune cells isolated from a subject, wherein gene expression can be modulated to enhance immune cell activity in the resulting expande...